Ceribell Reports 29% Revenue Growth to $26.5 Million in Q1 2026 Despite Increased Net Loss

Ceribell, Inc. reported its financial results for the first quarter of 2026, revealing a total revenue of $26.5 million, a 29% increase from $20.5 million in the same period of 2025. This growth was driven by a 29% rise in both product revenue, which reached $20.2 million, and subscription revenue, which totaled $6.3 million. Despite the revenue increase, the company recorded a net loss of $19.7 million, compared to a loss of $12.8 million in the prior year, reflecting a 54% increase in losses attributed to higher operating expenses.

The company's operating expenses surged to $43.9 million, a 36% increase from $32.2 million in the previous year. This rise was primarily due to increased spending in research and development, sales and marketing, and general and administrative expenses. Research and development costs rose by 45% to $6.2 million, while sales and marketing expenses increased by 24% to $22.4 million. General and administrative expenses saw a significant jump of 54%, reaching $15.3 million, largely due to legal costs associated with ongoing intellectual property enforcement activities.

Ceribell's operational metrics indicate a growing customer base, with the Ceribell System now adopted by over 650 hospitals across the United States. The company continues to focus on expanding its market presence, particularly in the acute care setting, where it aims to establish its system as the standard for seizure detection and management. The company has also received regulatory clearances for its products, including the FDA's 510(k) clearance for its Clarity device and delirium monitoring solution.

As of March 31, 2026, Ceribell reported $141.2 million in cash, cash equivalents, and marketable securities, down from $195.8 million at the end of 2025. The decrease in cash reserves is attributed to ongoing operational losses and investments in growth initiatives. The company anticipates that its existing cash and cash equivalents will be sufficient to fund operations for at least the next 12 months, although it may need to seek additional capital to support further growth and development.

Looking ahead, Ceribell plans to expand its sales organization to drive adoption of the Ceribell System and enhance utilization among existing customers. The company is also exploring opportunities for geographic expansion and additional regulatory clearances outside the United States. However, it acknowledges the potential risks associated with market acceptance, competition, and economic conditions that could impact its future financial performance.